Session » (1221–1247) Pain in Rheumatic Disease Including Fibromyalgia Poster
- 10:30AM-12:30PM
-
Abstract Number: 1225
Association between Anxiety and Tender Swollen Joint Difference in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1241
Beyond Pain Severity in Psoriatic Arthritis: Pain Catastrophizing Independently Impacts Disease Burden and Quality of Life
- 10:30AM-12:30PM
-
Abstract Number: 1243
Broad Cytokine Dysregulation in Fibromyalgia Patients: A Pilot Immune Profiling Study
- 10:30AM-12:30PM
-
Abstract Number: 1230
Chronic pain phenotypes in older adults: Identifying patterns of musculoskeletal pain and associated burden
- 10:30AM-12:30PM
-
Abstract Number: 1224
Comparative Effectiveness of Duloxetine versus Pregabalin in Fibromyalgia: A Large-Scale, Real-World Study Across 300,000 Patients
- 10:30AM-12:30PM
-
Abstract Number: 1235
Demystifying Pain in patients with Lupus: How much is it Lupus and How much is it Other Stuff?
- 10:30AM-12:30PM
-
Abstract Number: 1232
Does Social Support Reduce Bodily Pain among African American Women with SLE?: Findings from a Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1245
Efficacy And Safety of Low-dose Naltrexone In Fibromyalgia: An Updated Systematic Review And Meta-Analysis of Randomized Controlled Trials (RCTs)
- 10:30AM-12:30PM
-
Abstract Number: 1222
Efficacy of Fasinumab, An Anti-Nerve Growth Factor Monoclonal Antibody, in Managing Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis
- 10:30AM-12:30PM
-
Abstract Number: 1229
Extent versus impact: Sex-specific burden of chronic pain in older adults
- 10:30AM-12:30PM
-
Abstract Number: 1239
JAK inhibition appears to alter clinical and neurobiological markers of nociplastic pain in rheumatoid arthritis: a 7T MRI Brain study
- 10:30AM-12:30PM
-
Abstract Number: 1246
Myo Vs. Myo-fascial Injection for Myofascial Trigger Points. Is There Really a Difference? A Randomized Controlled Trial
- 10:30AM-12:30PM
-
Abstract Number: 1221
Oxytocin pathway gene BST1 polymorphism rs4273468 genotype GG is negatively associated with Fibromyalgia
- 10:30AM-12:30PM
-
Abstract Number: 1244
PACFiND: Co-Designing Principles To Inform Reconfiguration Of Fibromyalgia Care Across Health Systems
- 10:30AM-12:30PM
-
Abstract Number: 1223
Pain and Fibromyalgia Across Autoimmune and Inflammatory Diseases in the AMP AIM Cohort
- 10:30AM-12:30PM
-
Abstract Number: 1238
Pain Is Associated with An Increased Risk of Frailty in Veterans with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1226
Preliminary Findings in the Validation of the Modified Pain and Symptom Assessment Tool in Juvenile Fibromyalgia Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 1247
Relation of Measures of Pain Sensitization to Widespread Pain
- 10:30AM-12:30PM
-
Abstract Number: 1242
Relax the Body: Dual-Agent Nighttime Therapy for Fibromyalgia: Symptom Reduction Using Tricyclic Antidepressants and Muscle Relaxants
- 10:30AM-12:30PM
-
Abstract Number: 1234
Serum Antibodies Against Glial Fibrillary Acidic Protein in Fibromyalgia: A Proof-of-Concept Study
- 10:30AM-12:30PM
-
Abstract Number: 1240
Serum Olink Proteomics Identifies Novel Mediators of Pain in Lupus Nephritis Patients Without Extrarenal Clinical Activity
- 10:30AM-12:30PM
-
Abstract Number: 1237
Six Month Clinical Outcomes of a Digital Therapeutic Augmented Virtual Care Clinic for Fibromyalgia Management
- 10:30AM-12:30PM
-
Abstract Number: 1233
Synovial Joint Transcriptomic Differences in Individuals with Knee Osteoarthritis and Neuropathic Pain Symptomology
- 10:30AM-12:30PM
-
Abstract Number: 1227
The Composition of Circulating Immune Cells is Associated with Nociplastic Pain in Patients with Rheumatoid Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 1231
TNX-102 SL, Cyclobenzaprine HCl Sublingual Tablets, Demonstrates Pain Reduction and Favorable Tolerability in Patients with Fibromyalgia